Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes

Experimental Hematology

Volumn 35, Issue 3, 2007, Pages 416-425

  Brillard, Emilie ^a   Pallandre, Jean René ^a   Chalmers, David ^a   Ryffel, Bernhard ^b   Radlovic, Amandine ^a   Seilles, Estelle ^a   Rohrlich, Pierre Simon ^a   Pivot, Xavier ^a,c   Tiberghien, Pierre ^a   Saas, Philippe ^a   Borg, Christophe ^a,c  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^b CNRS   (France)

^c UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; RNA; TRANSCRIPTION FACTOR FOXP3;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DNA FLANKING REGION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; MALE; MOLECULAR INTERACTION; MOUSE; NATURAL KILLER CELL; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERODIAGNOSIS; TH1 CELL;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD28; ANTIGENS, CD4; ANTIGENS, CD45; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-2; KILLER CELLS, NATURAL; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES, REGULATORY; TRANSCRIPTION, GENETIC; TRANSPLANTATION, HETEROLOGOUS;

MURINAE; MUS;

EID: 33847219658     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2006.12.004     Document Type: Article

References (53)

1. Kiessling R., Klein E., and Wigzell H. Natural killer cells in the mouse I cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol 5 (1975) 112-117
2. Scharton T.M., and Scott P. Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J Exp Med 178 (1993) 567-577
3. Martin-Fontecha A., Thomsen L.L., Brett S., et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 5 (2004) 1260-1265
4. Fehniger T.A., Cooper M.A., Nuovo G.J., et al. CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 101 (2003) 3052-3057
5. Borg C., Jalil A., Laderach D., et al. NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs. Blood 104 (2004) 3267-3275
6. Ferlazzo G., and Munz C. NK cell compartments and their activation by dendritic cells. J Immunol 172 (2004) 1333-1339
7. Kelly J.M., Takeda K., Darcy P.K., Yagita H., and Smyth M.J. A role for IFN-gamma in primary and secondary immunity generated by NK cell-sensitive tumor-expressing CD80 in vivo. J Immunol 168 (2002) 4472-4479
8. Mocikat R., Braumuller H., Gumy A., et al. Natural killer cells activated by MHC class I(low) targets prime dendritic cells to induce protective CD8 T cell responses. Immunity 19 (2003) 561-569
9. Ghiringhelli F., Menard C., Terme M., et al. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. J Exp Med 202 (2005) 1075-1085
10. Letterio J.J., and Roberts A.B. Regulation of immune responses by TGF-beta. Annu Rev Immunol 16 (1998) 137-161
11. Huber S., Schramm C., Lehr H.A., et al. TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells. J Immunol 173 (2004) 6526-6531
12. Sakaguchi S., Fukuma K., Kuribayashi K., and Masuda T. Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J Exp Med 161 (1985) 72-87
13. Powrie F., Leach M.W., Mauze S., Caddle L.B., and Coffman R.L. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int Immunol 5 (1993) 1461-1471
14. Brunkow M.E., Jeffery E.W., Hjerrild K.A., et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 27 (2001) 68-73
15. Sakaguchi S., and Sakaguchi N. Organ-specific autoimmune disease induced in mice by elimination of T cell subsets. V. Neonatal administration of cyclosporin A causes autoimmune disease. J Immunol 142 (1989) 471-480
16. Singh B., Read S., Asseman C., et al. Control of intestinal inflammation by regulatory T cells. Immunol Rev 182 (2001) 190-200
17. Zhai Y., and Kupiec-Weglinski J.W. What is the role of regulatory T cells in transplantation tolerance?. Curr Opin Immunol 11 (1999) 497-503
18. Onizuka S., Tawara I., Shimizu J., Sakaguchi S., Fujita T., and Nakayama E. Tumor rejection by in vivo administration of anti-CD25 (interleukine-2receptor alpha) monoclonal antibody. Cancer Res 59 (1999) 3128-3133
19. Curiel T.J., Coukos G., Zou L., et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10 (2004) 942-949
20. Turk M.J., Guevara-Patino J.A., Rizzuto G.A., Engelhorn M.E., Sakaguchi S., and Houghton A.N. Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells. J Exp Med 200 (2004) 771-782
21. Viguier M., Lemaitre F., Verola O., et al. Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J Immunol 173 (2004) 1444-1453
22. Hiura T., Kagamu H., Miura S., et al. Both regulatory T cells and antitumor effector T cells are primed in the same draining lymph nodes during tumor progression. J Immunol 175 (2005) 5058-5066
23. Sato E., Olson S.H., Ahn J., et al. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci U S A 102 (2005) 18538-18543
24. Holdorf A.D., Lee K.H., Burack W.R., Allen P.M., and Shaw A.S. Regulation of Lck activity by CD4 and CD28 in the immunological synapse. Nat Immunol 3 (2002) 259-264
25. Tai X., Cowan M., Feigenbaum L., and Singer A. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat Immunol 6 (2005) 152-162
26. Liang S., Alard P., Zhao Y., Parnell S., Clark S.L., and Kosiewicz M.M. Conversion of CD4+ CD25- cells into CD4+ CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus. J Exp Med 201 (2005) 127-137
27. Walker M.R., Kasprowicz D.J., Gersuk V.H., et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J Clin Invest 112 (2003) 1437-1443
28. Allan S.E., Passerini L., Bacchetta R., et al. The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. J Clin Invest 115 (2005) 3276-3284
29. Fantini M.C., Becker C., Monteleone G., Pallone F., Galle P.R., and Neurath M.F. TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 172 (2004) 5149-5153
30. Chen W., Jin W., Hardegen N., et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198 (2003) 1875-1886
31. Laouar Y., Sutterwala F.S., Gorelik L., and Flavell R.A. Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma. Nat Immunol 6 (2005) 600-607
32. Lee J.C., Lee K.M., Kim D.W., and Heo D.S. Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients. J Immunol 172 (2004) 7335-7340
33. Hoffmann P., Ermann J., Edinger M., Fathman C.G., and Strober S. Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med 196 (2002) 389-399
34. Taylor P.A., Lees C.J., and Blazar B.R. The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 99 (2002) 3493-3499
35. Cohen J.L., Trenado A., Vasey D., Klatzmann D., and Salomon B.L. CD4(+)CD25(+) immunoregulatory T cells: new therapeutics for graft-versus-host disease. J Exp Med 196 (2002) 401-406
36. Chalifour A., Jeannin P., Gauchat J.F., et al. Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers alpha-defensin production. Blood 104 (2004) 1778-1783
37. Sivori S., Falco M., Della Chiesa M., et al. CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc Natl Acad Sci U S A 101 (2004) 10116-10121
38. Gerosa F., Gobbi A., Zorzi P., et al. The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. J Immunol 174 (2005) 727-734
39. Hernandez N.C., Lozier A., Flament C., et al. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 5 (1999) 405-411
40. Gerosa F., Baldani-Guerra B., Nisii C., Marchesini V., Carra G., and Trinchieri G. Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med 195 (2002) 327-333
41. Ferlazzo G., Pack M., Thomas D., et al. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc Natl Acad Sci U S A 101 (2004) 16606-16611
42. Ferlazzo G., Thomas D., Lin S.L., et al. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J Immunol 172 (2004) 1455-1462
43. Bajénoff M., Breart B., Huang A.Y., et al. Natural killer cell behavior in lymph nodes revealed by static and real-time imaging. J Exp Med 203 (2006) 619-631
44. Terme M., Tomasello E., Maruyama K., et al. IL-4 confers NK stimulatory capacity to murine dendritic cells: a signaling pathway involving KARAP/DAP12-triggering receptor expressed on myeloid cell 2 molecules. J Immunol 172 (2004) 5957-5966
45. Afkarian M., Sedy J.R., Yang J., et al. T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells. Nat Immunol 3 (2002) 549-557
46. Szabo S.J., Sullivan B.M., Stemmann C., Satoskar A.R., Sleckman B.P., and Glimcher L.H. Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 295 (2002) 338-342
47. Zingoni A., Sornasse T., Cocks B.G., Tanaka Y., Santoni A., and Lanier L.L. Cross-talk between activated human NK cells and CD4+ T cells via OX40-OX40 ligand interactions. J Immunol 173 (2004) 3716-3724
48. Nishikawa H., Kato T., Tawara I., et al. IFN-gamma controls the generation/activation of CD4+ CD25+ regulatory T cells in antitumor immune response. J Immunol 175 (2005) 4433-4440
49. Morgan M.E., van Bilsen J.H., Bakker A.M., et al. Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. Hum Immunol 66 (2005) 13-20
50. Powell B.R., Buist N.R., and Stenzel P. An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J Pediatr 100 (1982) 731-737
51. Satake N., Nakanishi M., Okano M., et al. A Japanese family of X-linked auto-immune enteropathy with haemolytic anaemia and polyendocrinopathy. Eur J Pediatr 152 (1993) 313-315
52. Bennett C.L., Christie J., Ramsdell F., et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27 (2001) 20-21
53. Schubert L.A., Jeffery E., Zhang Y., Ramsdell F., and Ziegler S.F. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J Biol Chem 276 (2001) 37672-37679